• You are here: 
  • CPRD News
  • Latest News

Latest News

Meet us at ICPE

Increase Font Size Decrease Font Size

CPRD will be presenting a number of studies at this year’s International Conference for Pharmacoepidemiology & Therapeutic Risk Management (ICPE), 28th-30th August 2017 in Montreal, Canada.   If you are attending the event, please come along to find out how CPRD data is being used to answer important public health and clinical research questions.

Or you can visit us at stand 13. You will have the opportunity to meet representatives from our observational and interventional research teams and business development colleagues. CPRD supports real world academic, regulatory and industry clinical research worldwide through innovative use of UK health data for observational research and low burden clinical trial management.

Symposium
Optimising design, conduct and interpretation of EHR-enabled randomised clinical trials: Case examples demonstrate the critical role of epidemiology and future challenges
Date/Time: Wednesday 30 August, 10:30-12:00
Room: 520CF
CPRD-GSK-University of Manchester (Mark Wright and Rachael Williams)

Oral presentations
Cardiovascular safety of vildagliptin: Pan-European non-interventional safety study
Date/Time: Monday 28 August, 17:00-18:30
Session: (Cardio) Vascular Safety Outcomes, 524AB
Rachael Williams

Posters
The use of acute hospital care by people with intellectual disabilities
Date/Time: Monday 28 August, 08:00-18:00
Session: Poster Session A: Health Care Utilisation & Costs, 220BC
Jessie Oyinlola and Rachael Williams

Pancreatic cancer and vildagliptin: post-hoc analysis of the pan-European non-interventional safety study
Date/Time: Monday 28 August, 08:00-18:00
Session: Poster Session A: Pharmacovigilance – Cancer, 220BC
Rachael Williams

Does pay-for-performance influence outcomes for people with serious mental illness?
Date/Time: Tuesday 29 August, 08:00-18:00
Session: Poster Session B: Informed Drug Policy, 220BC
Rachael Williams

Pancreatic safety of vildagliptin: Pan-European non-interventional safety study
Date/Time: Tuesday 29 August, 08:00-18:00
Session: Poster Session B: Pharmacovigilance – Diabetes, 220BC

Find out more about ICPE in Montreal  

Date: 15th August 2017

Our contact details have changed

We have changed the name of our customer services system from CPRD Knowledge Centre to CPRD Enquiries.

This means that emails you receive will be from CPRD Enquiries and we will use our new email address

This change is part of our ongoing improvements to the efficiency of the CPRD point of contact system, and better reflects that we are here to respond to general enquiries as well as complex questions.

Any emails sent to our old email address will continue to reach us over the next few months. Our telephone number will remain the same and log in details for the customer website will not change.

CPRD contact details page

Date: 02nd May 2017

Vacancies for Independent Scientific Advisory Committee Members

We are now seeking scientific members to join the MHRA Independent Scientific Advisory Committee (ISAC). We are interested in applicants with considerable expertise and research experience in select areas. For further information please click here

Data Linkages

Following the announcement in July CPRD has now implemented the amendment to its policy on release of linked data. Linked data will only be released once ISAC has approved the study protocol. This policy will apply to any study in which patient level data are analysed, whether or not the results of the analysis will be published or otherwise communicated to third parties.

The following are excluded from this policy:

  • Incidence and prevalence counts, cohort definitions and simple counts of patient numbers for feasibility purposes
  • Linkage between primary care data and small area socio-economic status scores, solely in circumstance in which the results of analysis will not be published or otherwise communicated to third parties

Please note that for any studies which are to be published or otherwise communicated to third parties, prior ISAC approval of the study protocol is already required.

If you have any queries about this message, or would like any further information, please contact us at

Data Linkages – Clarification

CPRD is implementing an amendment to its policy on release of linked data. Once the revised policy is implemented, linked data will only be released once ISAC has approved the study protocol. This policy will apply to any study in which patient level data are analysed, whether or not the results of the analysis will be published or otherwise communicated to third parties.

The following will be excluded from this policy:

  • incidence and prevalence counts, cohort definitions and simple counts of patient numbers for feasibility purposes
  • linkage between primary care data and small area socio-economic status scores, solely in circumstance in which the results of analysis will not be published or otherwise communicated to third parties

The revised policy will be implemented from 1st September 2016. Please note that for any studies which are to be published or otherwise communicated to third parties, prior ISAC approval of the study protocol is already required.

If you have any queries about this message, or would like any further information, please contact us at

Medicines and Healthcare products Regulatory Agency statement on the outcome of the EU referendum

The Agency's response to the outcome of the EU referendum

Following the result of the referendum on the UK’s membership of the European Union, the focus of the Medicines and Healthcare products Regulatory Agency continues to be on our public health role. We will continue to work to the highest levels of excellence and quality, working with and supporting our customers, partners and stakeholders to protect health and improve lives.

Working closely with government we will consider the implications for the work of the Agency. We will continue to make a major contribution globally to improving public health through the effective regulation of medicines and medical devices, underpinned by science and research.

Date: 27th June 2016

Approved studies using CPRD Data

Applications to access CPRD data for observational research are reviewed the Independent Scientific Advisory Committee (ISAC). Approval by ISAC is required for researchers to carry out their proposed studies.

A summary of all ISAC approved protocols, including a lay and technical summary of the proposed research, are published 3 months after researchers have access to the data to begin their study.

Please click here to access the full list of the approved protocols.